| NCT ID | NCT07141537 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute for Systems Biology |
| Condition | Metabolism |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-08-27 |
| Primary Completion | 2033-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2025-08-27 with a primary completion date of 2033-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of CaBooM is to identify and characterize biomarkers of caloric balance-the relationship between energy intake (calories consumed) and energy expenditure (calories burned).
Eligibility Criteria
Inclusion Criteria: * \> 18 years of age * Able to travel to ISB for study visits. * Able to read and communicate in English. Exclusion Criteria: * \- Unable to provide informed consent. * Is a prisoner.
Contact & Investigator
Jared C Roach, MD, PhD
PRINCIPAL INVESTIGATOR
Institute for Systems Biology
Frequently Asked Questions
Who can join the NCT07141537 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Metabolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07141537 currently recruiting?
Yes, NCT07141537 is actively recruiting participants. Contact the research team at caboom@isbscience.org for enrollment information.
Where is the NCT07141537 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT07141537 clinical trial?
NCT07141537 is sponsored by Institute for Systems Biology. The principal investigator is Jared C Roach, MD, PhD at Institute for Systems Biology. The trial plans to enroll 400 participants.